BioLoomics
About:
BioLoomics is a biotechnology company that develops antibodies for cancer therapies.
Website: https://bioloomics.com/
Top Investors: Hummingbird Ventures, Horizons Ventures, TechU Ventures, Boom Capital Ventures, Innovation Endeavors
Description:
BioLoomics is a biotechnology company that uses directed evolution to develop antibodies with programmable spatial fate in target cells.
Total Funding Amount:
$10.1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Boulder, Colorado, United States
Founded Date:
2019-01-01
Contact Email:
info(AT)bioloomics.com
Founders:
Doug Chapnick
Number of Employees:
11-50
Last Funding Date:
2023-09-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai